Hypertrophic cardiomyopathy: Prognostic factors and survival analysis in 128 Egyptian patients

Cardiology in the Young

Volumn 24, Issue 4, 2014, Pages 702-708

  El Saiedi, Sonia A ^a   Seliem, Zeinab S ^a   Esmail, Reem I ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

children; echocardiography; Hypertrophic cardiomyopathy

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; DISEASE DURATION; ECHOCARDIOGRAPHY; EGYPT; ELECTROCARDIOGRAPHY; FAMILY HISTORY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEWBORN; PHYSICAL EXAMINATION; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SINUS TACHYCARDIA; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; AGE; CLINICAL FEATURE; CRYOABLATION; DOPPLER ECHOCARDIOGRAPHY; EGYPTIAN; HEART SURGERY; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; M MODE ECHOCARDIOGRAPHY; MORTALITY; MUSCLE RESECTION; PACEMAKER IMPLANTATION; PRESCHOOL CHILD; SCHOOL CHILD; SUDDEN DEATH; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; HYPERTROPHY, LEFT VENTRICULAR; INFANT; SEVERITY OF ILLNESS INDEX; STATISTICS; TACHYCARDIA, SINUS; TACHYCARDIA, SUPRAVENTRICULAR;

ADOLESCENT; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; EGYPT; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TACHYCARDIA, SINUS; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 84903600358     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951113001030     Document Type: Article

References (31)

1. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008; 29: 270-276.
2. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287: 1308-1320. (Pubitemid 34250486)
3. Maron BJ, Towbin JA, Thiene G, et al. American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies. Circulation 2006; 113: 1807-1816.
4. Melacini P, Basso C, Angelini A, et al. Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J 2010; 31: 2011-2123.
5. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-1785. (Pubitemid 30390237)
6. Ostman-Smith I, Wettrell G, Riesenfeld TA. Cohort study of childhood hypertrophic cardiomyopathy: improved survival following highdose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 1999; 34: 113-122.
7. Nugent AW, Daubeney PE, Chondros P, et al. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 2005; 112: 1332-1338. (Pubitemid 41266729)
8. Colan SD, Lipshultz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 2007; 115: 773-781. (Pubitemid 46294745)
9. Maron BJ, McKenna WJ, Danielson GK, et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). Eur Heart J 2003; 24: 1965-1991. (Pubitemid 37336422)
10. Nasermoaddeli A, Miura K, Matsumori A, et al. Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart 2007; 93: 711-715. (Pubitemid 46808273)
11. Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ. Non-sustained ventricular tachycardia in hyper-trophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003; 42: 873-879. (Pubitemid 37059747)
12. Ostman-Smith I, Wettrell G, Keeton B, Riesenfeld T, Holmgren D, Ergander U. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 2005; 15: 632-642. (Pubitemid 41748558)
13. Harris KM, Spirito P, Maron MS, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006; 114: 216-225. (Pubitemid 44297115)
14. Grenier MA, Osganian SK, Cox GF, et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J 2000; 139: S86-S95. (Pubitemid 30091772)
15. Sluysmans T, Colan SD. Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol 2005; 99: 445-457. (Pubitemid 41061136)
16. Maron BJ, Tajik AJ, Ruttenberg HD, et al. Hypertrophic cardiomyopathy infants: clinical features and natural history. Circulation 1982; 65: 7-17. (Pubitemid 12250883)
17. Skinner JR, Manzoor A, Hayes AM, Joffe HS, Martin RP. A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants. Heart 1997; 77: 229-233. (Pubitemid 27122773)
18. Decker JA, Rossano JW, Smith EO, et al. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol 2009; 54: 250-254.
19. Maron BJ. Hypertrophic cardiomyopathy in childhood. Pediatr Clin N Am 2004; 51: 1305-1346. (Pubitemid 39157342)
20. Maron BJ, Spirito P. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol 1993; 72: 970-972. (Pubitemid 23298080)
21. Lewin MB, Towbin JA, Thapar MK, Dreyer WJ, Feltes TF. The rare association of tetralogy of Fallot with hypertrophic cardiomyopathy. Report of 2 neonatal patients. Tex Heart Inst J 1997; 24: 215-217.
22. Carvalho AM, Diógenes TC, Jucá ER, Carvalho AF, Carvalho CF, Paes Júnior JN. Tetralogy of Fallot and hypertrophic cardio-myopathy: a rare association. Arq Bras Cardiol 2003; 80: 217-219; 214-216.
23. Will PM, Serrian JL, Dawson JT. An unusual case of cyanotic heart disease in a patient with patent foramen ovale and right ventricular hypertrophy. Clin Cardiol 1996; 19: 429-432. (Pubitemid 26314311)
24. Nishimura RA, Holmes DR. Hypertrophic obstructive cardio-myopathy. N Engl J Med 2004; 350: 1320-1327.
25. McKenna WJ. The natural history of hypertrophic cardiomyopathy. Cardiovasc Clin 1988; 19: 135-148.
26. Yetman AT, Hamilton RM, Benson LN, McCrindle BW. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol 1998; 32: 1943-1950. (Pubitemid 29010459)
27. Moran AM, Colan SD. Verapamil therapy in infants with hypertrophic cardiomyopathy. Cardiol Young 1998; 8: 310-319. (Pubitemid 128681693)
28. McMahon CJ, Nagueh SF, Pignatelli RH, et al. Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy. Circulation 2004; 109: 1756-1762. (Pubitemid 38528696)
29. Olivotto I, Gistri R, Petrone P, et al. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 41: 315-321. (Pubitemid 36092203)
30. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 45: 697.
31. Cha Y-M, Gersh BJ, Maron BJ, et al. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2007; 18: 1-5.